Lv0
0 积分 2021-04-24 加入
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer
2个月前
已完结
Novel antibody-drug conjugates based on DXd-ADC technology
2个月前
已完结
962 A novel CD2-targeted costimulatory bispecific antibody platform for enhancing CD3 T cell engager-based cancer immunotherapy
5个月前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
5个月前
已完结
Artificial intelligence in drug development
6个月前
已完结
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
6个月前
已完结
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
7个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
8个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
9个月前
已完结
ABBV-303 is a Natural Killer Cell Engager Specific for c-Met-Expressing Tumors
9个月前
已完结
皖公网安备34019202002308
